MedPlast Adds Integer’s Surgical and Orthopedics Lines

MedPlast Adds Integer’s Surgical and Orthopedics Lines

MedPlast Inc., a portfolio company of JLL Partners and Water Street Healthcare Partners, announced the largest deal in the Medical Device sector in May 2018. The company, which provides integrated custom plastic processing solutions for finished medical devices, acquired the advanced surgical and orthopedics lines (ASO) from Integer (NYSE: ITGR) for $600 million. The transaction includes 10 manufacturing facilities. The ASO business comprises products and services for the laparoscopy, general surgery, biopsy and drug delivery, arthroscopic devices and components and orthopedic markets. Integer, formerly known as Greatbatch, rebranded in 2016 under the Integer name. With this acquisition,... Read More »
ResMed Adds HealthCareFirst to Home Health Solutions

ResMed Adds HealthCareFirst to Home Health Solutions

Medical device maker ResMed (NYSE: RMD) is moving deeper into the Home Health & Hospice arena. The company announced its acquisition of HealthCareFirst, which provides software solutions for home health and hospice agencies. HealthCareFirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics to help agencies optimize their clinical, financial and administrative processes. Financial terms were not disclosed. Pamlico Capital is the seller, having acquired HealthCareFirst in September 2012 from The Riverside Company. ResMed’s devices and software solutions help to treat and manage sleep apnea, chronic obstructive pulmonary disease... Read More »
ResMed Adds HealthCareFirst to Home Health Solutions

Sleep Disorders Make for Steady Business

For all the companies and remedies devoted to sleep disorders, it’s a wonder they haven’t been cured by now. The latest deal targeting a company focused on sleep apnea and other conditions was announced last week, on April 11. SleepScore Labs, a medical device company based in Carlsbad, California, acquired the Dutch technology company Sleep.ai for an undisclosed amount. SleepScore Labs was founded in 2016 and is a joint venture between Dr. Mehmet Oz, ResMed (NYSE: RMD) and Pegasus Capital Advisors. It is focused on improving sleep and uses ResMed’s SleepScore technology. ResMed specializes in cloud-connected devices for daily remote patient monitoring, to help treat and... Read More »
CooperSurgical Adds to Its IVF Business

CooperSurgical Adds to Its IVF Business

CooperSurgical (NYSE: COO), a subsidiary of The Cooper Companies, Inc., has added another medical device maker focused on women’s health. This is CooperSurgical’s first acquisition in 2018, and it didn’t go far from its Trumbull, Connecticut offices to find The LifeGlobal Group in Guilford, Connecticut. LifeGlobal is a leading provider of in vitro fertilization (IVF) products and devices, with operating facilities in the United States, Canada, Europe, Hong Kong and distributors in some 90 countries worldwide. The acquisition is expected to strengthen CooperSurgical’s fertility media offering and thus improve its industry leading fertility business overall. The deal... Read More »
Boston Scientific Makes Two Deals in March

Boston Scientific Makes Two Deals in March

Boston Scientific Corporation (NYSE: BSX) has had a busy month, and March 2018 isn’t over yet. On March 5, the medical device maker disclosed a deal for EMcision, Limited, based in Montreal, Quebec. The acquisition will expand the Boston Scientific Endoscopy portfolio to include the Habib EndoHPB probe, a novel endoscopic bipolar radiofrequency device, which coagulates tissue in the gastrointestinal tract. The Habib probe has been cleared by the U.S. FDA and received CE mark in the European Union. Although financial terms for the deal were not disclosed, BSX said the acquisition is expected to be immaterial to earnings per share in 2018 on an adjusted and GAAP basis and accretive... Read More »
Boston Scientific Makes Two Deals in March

Laborie Medical Takes Over Congentix Medical

Cogentix Medical, Inc. (NASDAQ: CGNT) is a global medical device company that offers products for flexible endoscopy and the treatment of overactive bladder and urinary incontinence. Its majority share owners, Accelmed Growth Partners LP and Mr. Lewis Pell, who collectively own approximately 60% of Cogentix Medical’s outstanding common stock, agreed to an offer of $3.85 per share (approximately $214 million) from Laborie Medical Technologies (LMT), a subsidiary of Patricia Industries.  The offer of $3.85 per share in cash represents a premium of 28% over the average closing price of Cogentix Medical common stock over the last 30 days. In July 2017, Cogentix paid $671,817 (£515,000)... Read More »